Human Adenovirus Type 35 Vector for Gene Therapy of Brain Cancer: Improved Transduction and Bypass of Pre-Existing Anti-Vector Immunity in Cancer Patients

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7701010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Development of PEGylated Adenovirus Vector for Cancer Gene Therapy

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2008English

Adenovirus as a Gene Therapy Vector for Hematopoietic Cells

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2000English

Biology of Adenovirus and Its Use as a Vector for Gene Therapy

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2004English

Generation of Optogenetically Modified Adenovirus Vector for Spatiotemporally Controllable Gene Therapy

English

Efficacy of Recombinant Adenovirus as Vector for Allergen Gene Therapy in a Mouse Model of Type I Allergy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2002English

Lentivirus-Mediated Platelet Gene Therapy of Murine Hemophilia a With Pre-Existing Anti-Factor VIII Immunity

Journal of Thrombosis and Haemostasis
MedicineHematology
2012English

The Use ofListeria Monocytogenesas a DNA Delivery Vector for Cancer Gene Therapy

Bioengineered Bugs
2010English

Seroprevalence of Neutralizing Antibodies Against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients

Frontiers in Immunology
AllergyImmunology
2018English

Development of the Hybrid Sleeping Beauty-Baculovirus Vector for Sustained Gene Expression and Cancer Therapy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy